Special Issue "Type 2 Diabetes and Insulin Resistance"
A special issue of Medicina (ISSN 1010-660X).
Deadline for manuscript submissions: 31 August 2019.
Dr. Domenico Sergi
Nutrition & Health Substantiation Group, Nutrition and Health Program, Health and Biosecurity, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Adelaide, SA, Australia
Website | E-Mail
Interests: nutrition and metabolic health; energy metabolism; obesity; type 2 diabetes; regulation of energy balance by the hypothalamus; lipotoxicity and fatty acid metabolism; mitochondria dysfunction and insulin resistance; metabolic inflammation
Type 2 diabetes has reached epidemic proportions worldwide and is projected to afflict more than 300 million individuals by the year 2025. Insulin resistance is the hallmark of type 2 diabetes and represents a pivotal metabolic defect in its pathogenesis. Given the importance of insulin resistance as a critical pathogenic factor leading to type 2 diabetes, the journal Medicina is launching a Special Issue entitled “Type 2 Diabetes and Insulin Resistance” with the aim of gathering together accurate and up-to-date scientific information on all aspects of insulin resistance and type 2 diabetes. We are pleased to invite you and your co-workers to submit your original research articles reporting on the biochemical and molecular aspects of insulin resistance including the pathophysiological mechanisms underpinning its development. We also encourage the submission of original manuscripts spanning basic to clinical research and focusing on dietary, lifestyle, and pharmacological interventions to prevent and/or ameliorate insulin resistance. We would also like to invite you to submit review articles aimed at providing a comprehensive overview of the recent advances in understanding the molecular basis of insulin resistance and its treatment and/or prevention.
Dr. Domenico Sergi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- insulin resistance
- type 2 diabetes
- metabolic syndrome
- carbohydrate metabolism
- lipid metabolism
- mitochondrial dysfunction